Patrick C W, Juneja H S, Lee S, Schmalstieg F C, McIntire L V
Department of Internal Medicine, University of Texas Health Science Center at Houston 77030.
Blood. 1995 Jan 1;85(1):168-78.
Heterotypic adherence between marrow stromal cells (MSC) and lymphoblastic cells is essential for normal lymphopoiesis and malignant lymphoblastic development. However, the detailed molecular mechanisms by which this heterotypic adherence occurs are poorly understood. The cell-cell interactions between a B-lymphoblastic cell line (UTMB-460) and a pre-B-cell line (NALM-6) with MSC were chosen as models to investigate potential mechanisms and adhesion molecules involved in the apposition between normal and malignant lymphoblastic cells and MSC. A parallel-flow detachment assay (PFDA) and a 51Cr detachment assay, coupled with monoclonal antibody (MoAb) blocking experiments, were used to quantify the attachment of lymphoblastic cells to confluent monolayers of MSC. The apposition between MSC and B-lymphoblastic cells (UTMB-460 cells) was investigated for variable time periods, ranging from 1 minute to 4 hours. Results from the temporal study suggest that the heterotypic adherence of the B-lymphoblastic cells to MSC is a biphasic event and the interactions occur rapidly (< or = 1 minute) after the two cells come into contact. More specifically, the early phase of adherence (< or = 15 minutes) solely involves very late antigen-4 alpha (VLA-4 alpha)/vascular cell adhesion molecule 1 (VCAM-1) interactions, as evidenced by the nearly complete inhibition (93%) of UTMB-460 cell adherence in the presence of anti-VLA-4 alpha. The late phase (> or = 30 minutes) proceeds despite the continuous presence of anti-VLA-4 alpha. In addition, the late-phase adherence is not affected by MoAbs to LFA-1, CD44, VCAM-1, E-selectin, or L-selectin, which suggests the possible involvement of other adhesion molecules. Adherence of pre-B-lymphoblastic cells (NALM-6) to MSC is also biphasic. Integrin VLA-4 is again a major player in the early phase of pre-B-lymphoblastic cell/MSC interactions. The early phase of adherence may be important in homing of the malignant lymphoblastic cells to the MSC and the late phase in retention of malignant lymphoblastic cells in the bone marrow.
骨髓基质细胞(MSC)与淋巴细胞之间的异型黏附对于正常淋巴细胞生成和恶性淋巴细胞发育至关重要。然而,这种异型黏附发生的详细分子机制尚不清楚。选择B淋巴细胞系(UTMB - 460)和前B细胞系(NALM - 6)与MSC之间的细胞 - 细胞相互作用作为模型,以研究参与正常和恶性淋巴细胞与MSC并置的潜在机制和黏附分子。采用平行流脱离试验(PFDA)和51Cr脱离试验,并结合单克隆抗体(MoAb)阻断实验,来量化淋巴细胞与MSC汇合单层的附着情况。研究了MSC与B淋巴细胞(UTMB - 460细胞)之间在1分钟至4小时不等的不同时间段的并置情况。时间研究结果表明,B淋巴细胞与MSC的异型黏附是一个双相事件,且两个细胞接触后相互作用迅速发生(≤1分钟)。更具体地说,黏附的早期阶段(≤15分钟)仅涉及极晚期抗原 - 4α(VLA - 4α)/血管细胞黏附分子1(VCAM - 1)相互作用,这由抗VLA - 4α存在时UTMB - 460细胞黏附的近乎完全抑制(93%)所证明。尽管抗VLA - 4α持续存在,晚期阶段(≥30分钟)仍会继续。此外,晚期黏附不受针对淋巴细胞功能相关抗原 - 1(LFA - 1)、CD44、VCAM - 1、E - 选择素或L - 选择素的单克隆抗体的影响,这表明可能有其他黏附分子参与。前B淋巴细胞(NALM - 6)与MSC的黏附也是双相的。整合素VLA - 4再次是前B淋巴细胞/MSC相互作用早期阶段的主要参与者。黏附的早期阶段可能对恶性淋巴细胞归巢至MSC很重要,而晚期阶段对恶性淋巴细胞在骨髓中的滞留很重要。